Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIA

Thalidomide Analogs AS TNF-ALPHA Modulators

  • Read more about Thalidomide Analogs AS TNF-ALPHA Modulators
Canada
2808646
Filed on 2004-09-17

Derivatives Of Uric Acid And Thiouric Acide For Oxidative Stress-Related Diseases.

  • Read more about Derivatives Of Uric Acid And Thiouric Acide For Oxidative Stress-Related Diseases.
European Patent
13155909.8
Filed on 2007-08-23

GLP-1 Exendin-4 Peptide Analogs and Uses Thereof

  • Read more about GLP-1 Exendin-4 Peptide Analogs and Uses Thereof
Japan
2013-007734
Filed on 2013-01-18

Human Soluble Receptor For Advanced Glycation End Products (sRAGE) Methods of Preparing Human Srage, And Treatment Methods Using Srage

  • Read more about Human Soluble Receptor For Advanced Glycation End Products (sRAGE) Methods of Preparing Human Srage, And Treatment Methods Using Srage
Patent Cooperation Treaty
PCT/US2013/020103
Filed on 2013-01-03

Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders

  • Read more about Combined IVIG And C1 Inhibitor Therapy For Neurological Disorders
Patent Cooperation Treaty
PCT/EP12/068643
Filed on 2012-09-21

The Use Of (2S,6S)-hydroxynorketamine And Other Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression

  • Read more about The Use Of (2S,6S)-hydroxynorketamine And Other Hydroxylated Metabolites Of (R,S)-ketamine In The Treatment Of Depression
Patent Cooperation Treaty
PCT/US12/60256
Filed on 2012-10-15

METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER

  • Read more about METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER
US Patent 10,077,296
Filed on 2012-08-16

THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS

  • Read more about THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS
US Patent 9,492,405
Filed on 2012-09-06

THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS

  • Read more about THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS
Japan
2012-557260
Filed on 2011-03-10

THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS

  • Read more about THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS
European Patent
11708381.6
Filed on 2011-03-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIA
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health